Geneos Wealth Management Inc. Procept Bio Robotics Corp Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 26 shares of PRCT stock, worth $1,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$1,778% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
271Shares Held
38.7MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$238 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$105 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$85.1 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$80.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.05B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...